SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (2976)12/2/1997 1:14:00 PM
From: MisterED  Read Replies (1) of 23519
 
Mike, even if the orals prove themselves, the market for Muse is firm
and there is every indication that Vivus will have strong earnings
next year. Are the orals hurting Vivus? Yes. But do they have to
tank for Vivus to do well? I don't believe that. Why would J&J
commit themselves if that was even a remote possibility. Even my
urologist questions the orals chance, for many reeasons (I never
told him I was an investor in Vivus).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News